Cargando…
Simulation contact lenses for AMD health state utility values in NICE appraisals: a different reality
BACKGROUND/AIMS: The National Institute for Health and Care Excellence (NICE) has recommended the use of ranibizumab for neovascular age-related macular degeneration (AMD) and for diabetic macular oedema (DMO) as part of its health technology appraisal process. In the economic evaluations of both in...
Autores principales: | Butt, Thomas, Crossland, Michael D, West, Peter, Orr, Shepley W, Rubin, Gary S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392203/ https://www.ncbi.nlm.nih.gov/pubmed/25351679 http://dx.doi.org/10.1136/bjophthalmol-2014-305802 |
Ejemplares similares
-
Microfluidic Contact Lenses
por: Jiang, Nan, et al.
Publicado: (2018) -
The impact of rarity in NICE’s health technology appraisals
por: Clarke, Sophie, et al.
Publicado: (2021) -
Contact Lenses for Color Blindness
por: Badawy, Abdel‐Rahman, et al.
Publicado: (2018) -
Decision making in NICE single technological appraisals: How does NICE incorporate patient perspectives?
por: Hashem, Ferhana, et al.
Publicado: (2017) -
Multifunctional transition and temperature-responsive contact lenses
por: Salih, Ahmed E., et al.
Publicado: (2023)